86
Participants
Start Date
July 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
insulin detemir
Treat-to-target, s.c. (under the skin) injection, once daily
insulin NPH
Treat-to-target, s.c. (under the skin) injection, once daily
Paris La Défense
Cambridge
Lead Sponsor
Novo Nordisk A/S
INDUSTRY